HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Meta-analysis
Pharmacist-led interventions reduce adverse reactions and improve outcomes in cancer patients
Pharmacist care reduces side effects and improves quality of life for cancer patients
This systematic review and meta-analysis of randomized controlled trials and non-randomized intervention studies evaluated pharmacist-led in…
Adding a pharmacist to cancer care teams significantly reduces nausea and vomiting while improving pain control and quality of life for pati…
Apr 9, 2026
Oncology
Meta-analysis
Meta-analysis finds no link between psychosocial factors and most cancer risks
Study links some psychosocial factors to higher lung cancer risk in large data review
This individual-participant data meta-analysis of 22 cohorts (N=421,799) found no association between psychosocial factors and overall cance…
Low social support, being single, or experiencing a loss are linked to higher lung cancer risk, but lifestyle factors like smoking may expla…
Apr 9, 2026
Rheumatology
Sys. Review
Antimicrobial peptides show anticancer activity via membrane disruption and immune priming in preclinical models
Review finds antimicrobial peptides show promise against cancer cells but clinical evidence remains limited
A systematic review of preclinical evidence finds antimicrobial peptides (AMPs) exhibit selective electrostatic interactions with malignant …
Antimicrobial peptides can selectively target and kill cancer cells by disrupting their membranes while also acting as vaccines to boost the…
Frontiers
Apr 9, 2026
Diabetes & Endocrinology
Sys. Review
Elevated plasma phenylalanine associated with obesity, type 2 diabetes, and cancer risk
High plasma phenylalanine linked to obesity, diabetes, and cancer risk
This systematic review examines epidemiological and mechanistic evidence regarding elevated plasma phenylalanine in metabolic disorders.
High blood phenylalanine is linked to obesity, type 2 diabetes, and cancer risk by blocking insulin signals and damaging mitochondria.
Frontiers
Apr 9, 2026
Oncology
Feasibility of combining ESPEN guidelines and Ayurvedic concepts to personalize diets for cancer patients
A small feasibility study found combining Ayurveda and standard guidelines is possible for cancer patients
This feasibility study evaluated personalized meal plans in 33 consenting adult cancer patients over 4 weeks to 6 months.
Personalized meals blending Ayurveda and standard cancer guidelines improved diet quantity for 33 adult cancer patients with no safety conce…
medRxiv
Apr 9, 2026
Geriatrics & Aging
Meta-analysis
Exercise reduces complications and improves function in frail elderly cancer patients on chemotherapy
Exercise helps frail elderly cancer patients undergoing chemotherapy avoid complications
A meta-analysis of 1,655 frail elderly cancer patients undergoing chemotherapy found exercise interventions significantly reduced complicati…
For frail elderly cancer patients on chemotherapy, exercise cuts complication risks by 60% while boosting energy and walking distance.
Apr 8, 2026
Genetics & Precision Medicine
Cohort
Population study links PALB2 variants to increased cancer risk and mortality in two large cohorts
Large study finds PALB2 gene variant linked to higher cancer risk and mortality
A case-control study of over 636,000 adults from UK Biobank and Geisinger MyCode cohorts found heterozygous PALB2 pathogenic/likely pathogen…
A common gene variant called PALB2 is linked to higher odds of breast, pancreatic, and other cancers plus reduced survival compared to peopl…
medRxiv
Apr 8, 2026
Primary Care & Family Medicine
Cohort
Prediction model for 30-day mortality in cancer patients with carbapenem-resistant organism infections
Researchers develop model to predict death risk in cancer patients with resistant infections
A retrospective cohort study of 417 cancer patients with CRO infections at Henan Cancer Hospital developed a 14-factor prediction model for …
A new tool predicts which cancer patients with hard-to-treat infections face the highest risk of dying within 30 days by analyzing 14 key fa…
Frontiers
Apr 8, 2026
Physical Medicine & Rehab
Survey finds 94% of cancer patients willing to try acupuncture for symptom relief
What do cancer patients want from acupuncture? A survey reveals their top hopes
A questionnaire survey of 511 cancer patients at Beijing Cancer Hospital found 481 (94.1%) were willing to receive acupuncture treatment.
Cancer patients overwhelmingly want acupuncture to help with sleep, pain, and fatigue, with 94% expressing willingness to try the treatment.
medRxiv
Apr 8, 2026
Anesthesiology & Pain Medicine
RCT
Pilot RCT finds mindfulness intervention feasible for chronic pain in cancer survivors
Can mindfulness help cancer survivors manage chronic pain? A small study explores
A pilot randomized controlled trial of 60 cancer survivors with moderate-to-severe chronic pain tested three formats of Mindfulness-Oriented…
Cancer survivors with chronic pain reported less bothersome and severe pain after a short mindfulness program, though the study was too smal…
Apr 7, 2026
Rheumatology
Cohort
Literature review associates TIVA and regional anesthesia with better immune preservation in cancer surgery
Anesthesia choices during cancer surgery may affect immune function and recurrence risk
A literature review synthesizing clinical trials, cohort studies, and meta-analyses suggests total intravenous anesthesia with propofol and …
Choosing anesthesia with propofol and regional blocks may help preserve immune cells that fight cancer, while high-dose opioids can reduce t…
Frontiers
Apr 7, 2026
Infectious Disease
Surveillance summary describes health care provision for 9/11-related conditions
Health program continues providing care for 9/11 responders and survivors
This surveillance summary describes health care provision for 9/11-related health conditions through the World Trade Center Health Program s…
Since 2011, the World Trade Center Health Program has provided health care for 9/11-related conditions among responders and survivors.
CDC
Apr 6, 2026